[HTML][HTML] GSK-3β: An exuberating neuroinflammatory mediator in Parkinson's disease

SS Khan, S Janrao, S Srivastava, SB Singh… - Biochemical …, 2023 - Elsevier
Neuroinflammation is a critical degradative condition affecting neurons in the brain.
Progressive neurodegenerative conditions such as Alzheimer's disease and Parkinson's …

Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms

ZD Wallen, A Demirkan, G Twa, G Cohen… - Nature …, 2022 - nature.com
Parkinson's disease (PD) may start in the gut and spread to the brain. To investigate the role
of gut microbiome, we conducted a large-scale study, at high taxonomic resolution, using …

[HTML][HTML] Beyond PDE4 inhibition: A comprehensive review on downstream cAMP signaling in the central nervous system

Z Donders, IJ Skorupska, E Willems, F Mussen… - Biomedicine & …, 2024 - Elsevier
Cyclic adenosine monophosphate (cAMP) is a key second messenger that regulates signal
transduction pathways pivotal for numerous biological functions. Intracellular cAMP levels …

Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson's disease

A Shojaie, S Rota, A Al Khleifat… - … Lateral Sclerosis and …, 2023 - Taylor & Francis
Amyotrophic lateral sclerosis and Parkinson's disease are neurodegenerative diseases of
the motor system which are now recognized also to affect non-motor pathways. Non-motor …

Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit

B Alharbi, HM Al-Kuraishy, AI Al-Gareeb… - European Journal of …, 2024 - Springer
Parkinson's disease (PD) is a progressive neurodegenerative disease as a result of the
degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc). The …

NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson's disease

M Khot, A Sood, KP Tryphena, S Khan… - European Journal of …, 2022 - Elsevier
Parkinson's disease (PD) is a common neurodegenerative condition for which no approved
treatment exists to prevent collective neuronal death. There is ample evidence that …

Integration of miRNA's theranostic potential with nanotechnology: promises and challenges for Parkinson's disease therapeutics

KP Tryphena, G Singh, N Jain, P Famta… - Mechanisms of Ageing …, 2023 - Elsevier
Despite the wide research going on in Parkinson's disease (PD), the burden of PD still
remains high and continues to increase. The current drugs available for the treatment of PD …

Decreased GABA levels of the anterior and posterior cingulate cortex are associated with executive dysfunction in mild cognitive impairment

X Fu, M Qin, X Liu, L Cheng, L Zhang… - Frontiers in …, 2023 - frontiersin.org
Background and purpose Executive function impairment, a slight but noticeable cognitive
deficit in mild cognitive impairment (MCI) patients, is influenced by gamma-aminobutyric …

Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies

G Magni, B Riboldi, S Ceruti - Cells, 2024 - mdpi.com
In vitro and preclinical in vivo research in the last 35 years has clearly highlighted the crucial
physiopathological role of glial cells, namely astrocytes/microglia/oligodendrocytes and …

In vitro astroglial dysfunction induced by neurotoxins: mimicking astrocytic metabolic alterations of Alzheimer's disease

J Taday, FT Fróes, M Seady, CA Gonçalves, MC Leite - Metabolites, 2024 - mdpi.com
Astrocytes play fundamental roles in the maintenance of brain homeostasis. The dysfunction
of these cells is widely associated with brain disorders, which are often characterized by …